Overview

Update
Acquisitions
1 Acquisition
IPO / Stock
Went Public on Nov 22, 2013 / NASDAQ:OXFD
Headquarters:
Abingdon, Oxfordshire
Description:
Oxford Immunotec, a medical diagnostics company, develops tests for various diseases based on its innovative T cell measurement technology.
Founders:
Categories:
Health Care, Biotechnology, Health Diagnostics
Website:
http://www.oxfordimmunotec.com
Social:

Company Details

Update

Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

Funding Rounds (4) - $106.52M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jun, 2012$28M / Venture8
May, 2010$26M / Series D7
Oct, 2007$40M / Series C6
Aug, 2005£7M / Series B3

Acquisitions (1)

Update
DateAcquiredAmount
Jun 23, 2016$22.2M in Cash

Current Team (2)

Update

Board Members and Advisors (1)

Update

Offices/Locations (3)

Update
  • Oxford Immunotec D&M

    94C Milton Park

    Abingdon

    Abingdon, Oxfordshire OX14 4RY

    United Kingdom

  • Oxford Immunotec Inc.

    2 Mount Royal Avenue, Suite 100

    Marlborough, Massachusetts MA 01792

    United States

  • Oxford Immunotec HQ

    115D Milton Park

    Abingdon

    Abingdon, Oxfordshire OX14 4RZ

    United Kingdom

Past Team (2)

Update

Images (1)

Update

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos